Literature DB >> 15511197

[Prevalence of atrial fibrillation and relationed factors in a population in the centre Madrid].

F J Candel1, M Matesanz, F Cogolludo, I Candel, C Mora, T Bescos, M Martín, I Vila i Costa.   

Abstract

INTRODUCTION: Atrial fibrillation is the most common arrhythmia on clinical practice and an important risk factor for ictus. The aim of this study was to know the prevalence of this arrythmia in a central district of Madrid.
MATERIAL AND METHODS: A retrospective study was done analysing medical records of 13,945 patients belonging to a primary care centre of Madrid. Time of study: recruitment of data from September 2000 to May 2001; analysis of data: from September 2001 to May 2002.
RESULTS: We obtained a total of 425 atrial fibrillations, 348 non-valvular and 77 valvular. Global prevalence of atrial fibrillation in patients over 40 years in our area was 2.52%. (2.47% male, 2.55% female). Risk factors for atrial fibrillation more frequently found in non-valvular were high blood pressure (HBP), diabetes, ischaemic heart disease and left ventricular dysfunction. Among valvulars we found HBP, left atrial size over 45 mm and left ventricular dysfunction.
CONCLUSIONS: Atrial fibrillation shows a prevalence and distribution in the studied area similar to that found in other European countries.

Entities:  

Mesh:

Year:  2004        PMID: 15511197     DOI: 10.4321/s0212-71992004001000003

Source DB:  PubMed          Journal:  An Med Interna        ISSN: 0212-7199


  4 in total

Review 1.  Risk analysis of new oral anticoagulants for gastrointestinal bleeding and intracranial hemorrhage in atrial fibrillation patients: a systematic review and network meta-analysis.

Authors:  Wei-Wei Xu; Shen-Jiang Hu; Tao Wu
Journal:  J Zhejiang Univ Sci B       Date:  2017-07       Impact factor: 3.066

2.  [Fibrilación auricular de primera vez en evento vascular cerebral isquémico en el servicio de urgencias].

Authors:  Franklin Ríos-Jaimes; Olivia A Otero-González; Enrique Villarreal-Ríos; M Carlota García-Gutiérrez
Journal:  Arch Cardiol Mex       Date:  2021-11-01

3.  Direct vitamin K antagonist anticoagulant treatment health care costs in patients with non-valvular atrial fibrillation.

Authors:  Álvaro Hidalgo-Vega; Elham Askari; Rosa Vidal; Isaac Aranda-Reneo; Almudena Gonzalez-Dominguez; Alexandra Ivanova; Gabriela Ene; Pilar Llamas
Journal:  BMC Health Serv Res       Date:  2014-01-30       Impact factor: 2.655

4.  Burden of disease from atrial fibrillation in adults from seven countries in Latin America.

Authors:  Luz Cubillos; Alexandra Haddad; Andreas Kuznik; Joaquin Mould-Quevedo
Journal:  Int J Gen Med       Date:  2014-09-02
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.